$296.31
-0.19-0.06%
At close: -
$296.31
0.000.00%
After Hours: Apr 11, 4:00 PM EDT
Comments
Loading...
Ansys Analyst Ratings and Price Targets | NASDAQ:ANSS | Benzinga
Ansys Inc has a consensus price target of $319.17 based on the ratings of 14 analysts. The high is $365 issued by Baird on November 7, 2024. The low is $274 issued by Credit Suisse on November 4, 2022. The 3 most-recent analyst ratings were released by Rosenblatt, Baird, and Rosenblatt on February 21, 2025, November 7, 2024, and August 6, 2024, respectively. With an average price target of $346.67 between Rosenblatt, Baird, and Rosenblatt, there's an implied 16.99% upside for Ansys Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Rosenblatt
Baird
Barclays
Mizuho
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Ansys
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/21/2025 | Buy Now | 14.74% | Rosenblatt | Blair Abernethy65% | $335 → $340 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | 23.18% | Baird | Joe Vruwink63% | $350 → $365 | Maintains | Outperform | Get Alert |
| 08/06/2024 | Buy Now | 13.06% | Rosenblatt | Blair Abernethy65% | $345 → $335 | Maintains | Neutral | Get Alert |
| 06/27/2024 | Buy Now | — | Keybanc | Jason Celino59% | — | Initiates | → Sector Weight | Get Alert |
| 05/03/2024 | Buy Now | 16.43% | Rosenblatt | Blair Abernethy65% | $345 → $345 | Maintains | Neutral | Get Alert |
| 03/05/2024 | Buy Now | 16.43% | Rosenblatt | Blair Abernethy65% | → $345 | Reiterates | Neutral → Neutral | Get Alert |
| 02/22/2024 | Buy Now | 14.74% | Barclays | Saket Kalia76% | $314 → $340 | Maintains | Underweight | Get Alert |
| 01/17/2024 | Buy Now | 11.37% | Mizuho | Matthew Broome58% | $350 → $330 | Maintains | Neutral | Get Alert |
| 01/17/2024 | Buy Now | — | Wolfe Research | Joshua Tilton58% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/17/2024 | Buy Now | 16.43% | Rosenblatt | Blair Abernethy65% | $332 → $345 | Downgrade | Buy → Neutral | Get Alert |
| 11/14/2023 | Buy Now | -0.44% | B of A Securities | Andrew Obin69% | $356 → $295 | Downgrade | Buy → Underperform | Get Alert |
| 11/06/2023 | Buy Now | -2.13% | Mizuho | Matthew Broome58% | $310 → $290 | Maintains | Neutral | Get Alert |
| 11/03/2023 | Buy Now | 12.04% | Rosenblatt | Blair Abernethy65% | $320 → $332 | Maintains | Buy | Get Alert |
| 11/03/2023 | Buy Now | 8% | Oppenheimer | Ken Wong68% | $400 → $320 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | -2.13% | RBC Capital | Matthew Hedberg75% | $310 → $290 | Maintains | Sector Perform | Get Alert |
| 08/04/2023 | Buy Now | 4.62% | RBC Capital | Matthew Hedberg75% | → $310 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 08/04/2023 | Buy Now | 8% | Rosenblatt | Blair Abernethy65% | → $320 | Reiterates | Buy → Buy | Get Alert |
| 07/14/2023 | Buy Now | 2.26% | Barclays | Saket Kalia76% | $292 → $303 | Maintains | Underweight | Get Alert |
| 05/05/2023 | Buy Now | 15.08% | Citigroup | Tyler Radke68% | $347 → $341 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | 4.62% | RBC Capital | Matthew Hedberg75% | $292 → $310 | Maintains | Sector Perform | Get Alert |
| 04/24/2023 | Buy Now | 17.11% | Citigroup | Tyler Radke68% | $326 → $347 | Maintains | Neutral | Get Alert |
| 04/18/2023 | Buy Now | 6.31% | Loop Capital | Mark Schappel42% | $310 → $315 | Maintains | Hold | Get Alert |
| 04/17/2023 | Buy Now | -5.5% | Mizuho | Matthew Broome58% | $260 → $280 | Maintains | Neutral | Get Alert |
| 04/13/2023 | Buy Now | -1.45% | Barclays | Saket Kalia76% | $266 → $292 | Maintains | Underweight | Get Alert |
| 02/27/2023 | Buy Now | 1.25% | JP Morgan | Stephen Tusa66% | $275 → $300 | Maintains | Overweight | Get Alert |
| 02/27/2023 | Buy Now | 4.62% | Rosenblatt | Blair Abernethy65% | $270 → $310 | Maintains | Buy | Get Alert |
| 02/24/2023 | Buy Now | -1.45% | RBC Capital | Matthew Hedberg75% | $248 → $292 | Maintains | Sector Perform | Get Alert |
| 02/24/2023 | Buy Now | -12.25% | Mizuho | Matthew Broome58% | $220 → $260 | Maintains | Neutral | Get Alert |
| 02/24/2023 | Buy Now | 10.36% | Baird | Joe Vruwink63% | $305 → $327 | Maintains | Outperform | Get Alert |
| 02/24/2023 | Buy Now | 4.62% | Rosenblatt | Blair Abernethy65% | $270 → $310 | Maintains | Buy | Get Alert |
| 02/06/2023 | Buy Now | 2.93% | Baird | Joe Vruwink63% | $295 → $305 | Maintains | Outperform | Get Alert |
| 01/11/2023 | Buy Now | -23.73% | Barclays | Saket Kalia76% | $200 → $226 | Maintains | Underweight | Get Alert |
| 12/14/2022 | Buy Now | -0.44% | Baird | Joe Vruwink63% | $281 → $295 | Upgrade | Neutral → Outperform | Get Alert |
| 12/08/2022 | Buy Now | -25.75% | Mizuho | Matthew Broome58% | $210 → $220 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | -29.13% | Mizuho | Matthew Broome58% | $225 → $210 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | -16.3% | RBC Capital | Matthew Hedberg75% | $260 → $248 | Maintains | Sector Perform | Get Alert |
| 11/04/2022 | Buy Now | -7.53% | Credit Suisse | John Walsh78% | $319 → $274 | Maintains | Outperform | Get Alert |
| 10/24/2022 | Buy Now | -8.88% | Rosenblatt | Blair Abernethy65% | $295 → $270 | Upgrade | Neutral → Buy | Get Alert |
| 10/17/2022 | Buy Now | -24.07% | Mizuho | Matthew Broome58% | $285 → $225 | Maintains | Neutral | Get Alert |
| 09/19/2022 | Buy Now | -7.19% | JP Morgan | Stephen Tusa66% | → $275 | Reinstates | → Overweight | Get Alert |
| 08/17/2022 | Buy Now | 8% | Wolfe Research | Gal Munda52% | → $320 | Initiates | → Outperform | Get Alert |
| 08/05/2022 | Buy Now | -15.63% | Barclays | Saket Kalia76% | $245 → $250 | Maintains | Underweight | Get Alert |
| 07/27/2022 | Buy Now | -3.82% | Oppenheimer | Ken Wong68% | → $285 | Initiates | → Outperform | Get Alert |
| 07/21/2022 | Buy Now | -3.82% | Rosenblatt | Blair Abernethy65% | $315 → $285 | Maintains | Neutral | Get Alert |
| 07/19/2022 | Buy Now | -10.57% | Mizuho | Matthew Broome58% | $285 → $265 | Maintains | Neutral | Get Alert |
| 06/13/2022 | Buy Now | 8% | Credit Suisse | John Walsh78% | $339 → $320 | Maintains | Outperform | Get Alert |
| 05/06/2022 | Buy Now | 14.41% | Credit Suisse | John Walsh78% | $389 → $339 | Maintains | Outperform | Get Alert |
| 05/06/2022 | Buy Now | 6.31% | Rosenblatt | Blair Abernethy65% | $324 → $315 | Maintains | Neutral | Get Alert |
| 05/06/2022 | Buy Now | -3.82% | Mizuho | Matthew Broome58% | $310 → $285 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Ansys (ANSS) stock?
The latest price target for Ansys (NASDAQ:ANSS) was reported by Rosenblatt on February 21, 2025. The analyst firm set a price target for $340.00 expecting ANSS to rise to within 12 months (a possible 14.74% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ansys (ANSS)?
The latest analyst rating for Ansys (NASDAQ:ANSS) was provided by Rosenblatt, and Ansys maintained their neutral rating.
When was the last upgrade for Ansys (ANSS)?
The last upgrade for Ansys Inc happened on December 14, 2022 when Baird raised their price target to $295. Baird previously had a neutral for Ansys Inc.
When was the last downgrade for Ansys (ANSS)?
The last downgrade for Ansys Inc happened on January 17, 2024 when Wolfe Research changed their price target from N/A to N/A for Ansys Inc.
When is the next analyst rating going to be posted or updated for Ansys (ANSS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ansys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ansys was filed on February 21, 2025 so you should expect the next rating to be made available sometime around February 21, 2026.
Is the Analyst Rating Ansys (ANSS) correct?
While ratings are subjective and will change, the latest Ansys (ANSS) rating was a maintained with a price target of $335.00 to $340.00. The current price Ansys (ANSS) is trading at is $296.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.